Los puntos clave no están disponibles para este artículo en este momento.
Focal chromosomal alterations and oncogenic drivers differ between KRAS WT and mutant pancreatic cancer
Share your take
Add a clinician perspective alongside expert commentary.
Singh et al. (Mon,) studied this question.